WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TBPH

Based on 5 analysts offering 12 month price targets for Theravance Biopharma Inc

Min Forecast
$14.00-7.83%
Avg Forecast
$18.40+21.13%
Max Forecast
$27.00+77.75%

Should I buy or sell TBPH stock?

Based on 5 analysts offering ratings for Theravance Biopharma Inc.

Buy
Strong Buy
1 analysts 20%
Buy
2 analysts 40%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their TBPH stock forecasts and price targets.

TBPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-23
lockedlocked$00.00+00.00%2026-03-20
lockedlocked$00.00+00.00%2026-03-04
lockedlocked$00.00+00.00%2026-03-04
lockedlocked$00.00+00.00%2025-12-03

1 of 1

Forecast return on equity

Is TBPH forecast to generate an efficient return?

Company
8.41%
Industry
68.89%
Market
178.41%
TBPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TBPH forecast to generate an efficient return on assets?

Company
5.14%
Industry
31.74%
TBPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TBPH earnings per share forecast

What is TBPH's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.96-54.1%
Avg 2 year Forecast
-$0.05-102.52%
Avg 3 year Forecast
$0.82-60.82%
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

TBPH revenue forecast

What is TBPH's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$117.7M+9.51%
Avg 2 year Forecast
$90.4M-15.91%
Avg 3 year Forecast
$182.4M+69.7%
TBPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TBPH earnings growth forecast

How is TBPH forecast to perform vs Biotechnology companies and vs the US market?

Company
-44.65%
Industry
11.92%
Market
35.8%
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
TBPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

TBPH revenue growth forecast

How is TBPH forecast to perform vs Biotechnology companies and vs the US market?

Company
14.13%
Industry
35.21%
Market
13.36%
TBPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TBPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TBPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TBPH$15.29$18.40+20.34%Buy
SPRY$7.90N/AN/A
MRVI$3.11$4.50+44.69%Strong Buy
KURA$8.55$28.00+227.49%Strong Buy
MPLT$18.14$31.80+75.30%Strong Buy
View Top Biotech Stocks

Theravance Biopharma Stock Forecast FAQ

Is Theravance Biopharma Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: TBPH) stock is to Buy TBPH stock.

Out of 5 analysts, 1 (20%) are recommending TBPH as a Strong Buy, 2 (40%) are recommending TBPH as a Buy, 2 (40%) are recommending TBPH as a Hold, 0 (0%) are recommending TBPH as a Sell, and 0 (0%) are recommending TBPH as a Strong Sell.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.

What is TBPH's earnings growth forecast for 2026-2028?

(NASDAQ: TBPH) Theravance Biopharma's forecast annual earnings growth rate of -44.65% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.8%.

Theravance Biopharma's earnings in 2026 is $105,895,000.On average, 9 Wall Street analysts forecast TBPH's earnings for 2026 to be $49,634,029, with the lowest TBPH earnings forecast at $9,587,982, and the highest TBPH earnings forecast at $70,287,841. On average, 8 Wall Street analysts forecast TBPH's earnings for 2027 to be -$2,729,125, with the lowest TBPH earnings forecast at -$44,912,128, and the highest TBPH earnings forecast at $74,072,571.

In 2028, TBPH is forecast to generate $42,368,378 in earnings, with the lowest earnings forecast at $10,092,613 and the highest earnings forecast at $107,053,789.

What is TBPH's revenue growth forecast for 2026-2028?

(NASDAQ: TBPH) Theravance Biopharma's forecast annual revenue growth rate of 14.13% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.21%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.36%.

Theravance Biopharma's revenue in 2026 is $107,464,000.On average, 9 Wall Street analysts forecast TBPH's revenue for 2026 to be $6,059,687,296, with the lowest TBPH revenue forecast at $4,137,971,373, and the highest TBPH revenue forecast at $9,964,910,652. On average, 8 Wall Street analysts forecast TBPH's revenue for 2027 to be $4,653,312,556, with the lowest TBPH revenue forecast at $4,289,360,569, and the highest TBPH revenue forecast at $5,081,012,783.

In 2028, TBPH is forecast to generate $9,390,764,550 in revenue, with the lowest revenue forecast at $4,491,212,831 and the highest revenue forecast at $13,844,387,547.

What is TBPH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TBPH) forecast ROA is 5.14%, which is lower than the forecast US Biotechnology industry average of 31.74%.

What is TBPH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year TBPH price target, the average TBPH price target is $18.40, with the highest TBPH stock price forecast at $27.00 and the lowest TBPH stock price forecast at $14.00.

On average, Wall Street analysts predict that Theravance Biopharma's share price could reach $18.40 by Mar 23, 2027. The average Theravance Biopharma stock price prediction forecasts a potential upside of 20.34% from the current TBPH share price of $15.29.

What is TBPH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TBPH) Theravance Biopharma's current Earnings Per Share (EPS) is $2.10. On average, analysts forecast that TBPH's EPS will be $0.96 for 2026, with the lowest EPS forecast at $0.19, and the highest EPS forecast at $1.37. On average, analysts forecast that TBPH's EPS will be -$0.05 for 2027, with the lowest EPS forecast at -$0.87, and the highest EPS forecast at $1.44. In 2028, TBPH's EPS is forecast to hit $0.82 (min: $0.20, max: $2.08).

What is TBPH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TBPH) forecast ROE is 8.41%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.